• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过可变剪接以所需比例实现蛋白质亚基的可调表达。

Alternative splicing for tuneable expression of protein subunits at desired ratios.

作者信息

Aebischer-Gumy Christel, Moretti Pierre, Brunstein Laplace Timothee, Frank Jana, Grand Ysaline, Mosbaoui Farid, Hily Emilie, Galea Anna, Peltret Megane, Estoppey Carole, Ayoub Daniel, Giovannini Roberto, Bertschinger Martin

机构信息

Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, Switzerland.

Antibody Engineering, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, Switzerland.

出版信息

MAbs. 2024 Jan-Dec;16(1):2342243. doi: 10.1080/19420862.2024.2342243. Epub 2024 Apr 22.

DOI:10.1080/19420862.2024.2342243
PMID:38650451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11042056/
Abstract

The controlled expression of two or more proteins at a defined and stable ratio remains a substantial challenge, particularly in the bi- and multispecific antibody field. Achieving an optimal ratio of protein subunits can facilitate the assembly of multimeric proteins with high efficiency and minimize the production of by-products. In this study, we propose a solution based on alternative splicing, enabling the expression of a tunable and predefined ratio of two distinct polypeptide chains from the same pre-mRNA under the control of a single promoter. The pre-mRNA used in this study contains two open reading frames situated on separate exons. The first exon is flanked by two copies of the chicken troponin intron 4 (cTNT-I4) and is susceptible to excision from the pre-mRNA by means of alternative splicing. This specific design enables the modulation of the splice ratio by adjusting the strength of the splice acceptor. To illustrate this approach, we developed constructs expressing varying ratios of GFP and dsRED and extended their application to multimeric proteins such as monoclonal antibodies, achieving industrially relevant expression levels (>1 g/L) in a 14-day fed-batch process. The stability of the splice ratio was confirmed by droplet digital PCR in a stable pool cultivated over a 28-day period, while product quality was assessed via intact mass analysis, demonstrating absence of product-related impurities resulting from undesired splice events. Furthermore, we showcased the versatility of the construct by expressing two subunits of a bispecific antibody of the BEAT® type, which contains three distinct subunits in total.

摘要

以确定且稳定的比例对两种或更多种蛋白质进行可控表达仍然是一项重大挑战,尤其是在双特异性和多特异性抗体领域。实现蛋白质亚基的最佳比例能够促进多聚体蛋白质高效组装,并将副产物的产生降至最低。在本研究中,我们提出了一种基于可变剪接的解决方案,可在单个启动子的控制下,从同一前体mRNA表达两种不同多肽链的可调且预定义比例。本研究中使用的前体mRNA包含位于不同外显子上的两个开放阅读框。第一个外显子两侧有两份鸡肌钙蛋白内含子4(cTNT-I4),可通过可变剪接从前体mRNA中切除。这种特殊设计能够通过调节剪接受体的强度来调控剪接比例。为说明该方法,我们构建了表达不同比例绿色荧光蛋白(GFP)和红色荧光蛋白(dsRED)的载体,并将其应用扩展至多聚体蛋白,如单克隆抗体,在14天的补料分批培养过程中实现了工业相关的表达水平(>1 g/L)。通过液滴数字PCR在培养28天的稳定细胞库中确认了剪接比例的稳定性,同时通过完整质量分析评估了产品质量,结果表明不存在由不期望的剪接事件导致的与产品相关的杂质。此外,我们通过表达BEAT®型双特异性抗体的两个亚基展示了该载体的多功能性,该双特异性抗体总共包含三个不同的亚基。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/89db2178bb4f/KMAB_A_2342243_F0009_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/a216954d6cc0/KMAB_A_2342243_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/7a05569ec9b6/KMAB_A_2342243_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/ed1584a1a256/KMAB_A_2342243_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/8750a918f22a/KMAB_A_2342243_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/71bb934c6e45/KMAB_A_2342243_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/5faace3e28e8/KMAB_A_2342243_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/67290d00aad0/KMAB_A_2342243_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/716bfe2edaa3/KMAB_A_2342243_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/89db2178bb4f/KMAB_A_2342243_F0009_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/a216954d6cc0/KMAB_A_2342243_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/7a05569ec9b6/KMAB_A_2342243_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/ed1584a1a256/KMAB_A_2342243_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/8750a918f22a/KMAB_A_2342243_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/71bb934c6e45/KMAB_A_2342243_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/5faace3e28e8/KMAB_A_2342243_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/67290d00aad0/KMAB_A_2342243_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/716bfe2edaa3/KMAB_A_2342243_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdb/11042056/89db2178bb4f/KMAB_A_2342243_F0009_OC.jpg

相似文献

1
Alternative splicing for tuneable expression of protein subunits at desired ratios.通过可变剪接以所需比例实现蛋白质亚基的可调表达。
MAbs. 2024 Jan-Dec;16(1):2342243. doi: 10.1080/19420862.2024.2342243. Epub 2024 Apr 22.
2
Cis requirements for alternative splicing of the cardiac troponin T pre-mRNA.心肌肌钙蛋白T前体mRNA可变剪接的顺式作用元件要求
Nucleic Acids Res. 1988 Sep 12;16(17):8443-65. doi: 10.1093/nar/16.17.8443.
3
Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.调控II型胶原蛋白(Col2)前体mRNA软骨特异性可变剪接的顺式作用内含子元件位于该基因外显子2侧翼的剪接位点连接序列处或其附近。
J Bone Miner Res. 2003 Sep;18(9):1716-22. doi: 10.1359/jbmr.2003.18.9.1716.
4
The architecture of pre-mRNAs affects mechanisms of splice-site pairing.前体信使核糖核酸的结构影响剪接位点配对机制。
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16176-81. doi: 10.1073/pnas.0508489102. Epub 2005 Oct 31.
5
Trans-splicing and alternative-tandem-cis-splicing: two ways by which mammalian cells generate a truncated SV40 T-antigen.反式剪接和交替串联顺式剪接:哺乳动物细胞产生截短型SV40 T抗原的两种方式。
Nucleic Acids Res. 1996 May 1;24(9):1653-61. doi: 10.1093/nar/24.9.1653.
6
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.通过应用连续灌注原理提高双特异性分子的产品质量和生产力。
Biotechnol Prog. 2020 Jul;36(4):e2973. doi: 10.1002/btpr.2973. Epub 2020 Feb 13.
7
Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing.心肌肌钙蛋白T可变外显子内的核苷酸替换会破坏前体mRNA的可变剪接。
Nucleic Acids Res. 1989 Oct 11;17(19):7905-21. doi: 10.1093/nar/17.19.7905.
8
Donor site competition is involved in the regulation of alternative splicing of the rat beta-tropomyosin pre-mRNA.供体位点竞争参与大鼠β-原肌球蛋白前体mRNA可变剪接的调控。
RNA. 1999 Feb;5(2):290-301. doi: 10.1017/s1355838299980743.
9
Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA: positive and negative regulations.鸡β-原肌球蛋白前体mRNA两个相互排斥外显子的组织特异性剪接:正负调控
Biochimie. 1996;78(6):457-65. doi: 10.1016/0300-9084(96)84752-3.
10
Expression of Bispecific Antibodies Using Cellular Display.细胞展示技术表达双特异性抗体
Methods Mol Biol. 2024;2810:181-196. doi: 10.1007/978-1-0716-3878-1_12.

引用本文的文献

1
Sequence and Configuration of a Novel Bispecific Antibody Format Impacts Its Production Using Chinese Hamster Ovary (CHO) Cells.一种新型双特异性抗体形式的序列和构型对其利用中国仓鼠卵巢(CHO)细胞生产的影响。
Biotechnol Bioeng. 2025 Feb;122(2):435-444. doi: 10.1002/bit.28879. Epub 2024 Nov 25.

本文引用的文献

1
Development of a 10 g/L process for a difficult-to-express multispecific antibody format using a holistic process development approach.采用整体工艺开发方法开发 10g/L 表达困难的多特异性抗体工艺。
J Biotechnol. 2024 Jun 20;389:30-42. doi: 10.1016/j.jbiotec.2024.04.017. Epub 2024 Apr 27.
2
Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions.一种双顺反子抗CD19/CD20嵌合抗原受体构建体的开发,包括消除意外的核酸序列缺失。
Mol Ther Oncolytics. 2023 Jul 19;30:132-149. doi: 10.1016/j.omto.2023.07.001. eCollection 2023 Sep 21.
3
VERITAS: Harnessing the power of nomenclature in biologic discovery.
VERITAS:在生物发现中利用命名法的力量。
MAbs. 2023 Jan-Dec;15(1):2207232. doi: 10.1080/19420862.2023.2207232.
4
Expression liabilities in a four-chain bispecific molecule.四链双特异性分子中的表达相关毒性。
Biotechnol Bioeng. 2021 Oct;118(10):3744-3759. doi: 10.1002/bit.27850. Epub 2021 Jun 15.
5
The Unfolded Protein Response: An Overview.未折叠蛋白反应:概述
Biology (Basel). 2021 Apr 29;10(5):384. doi: 10.3390/biology10050384.
6
Tailoring translational strength using Kozak sequence variants improves bispecific antibody assembly and reduces product-related impurities in CHO cells.通过使用 Kozak 序列变体来调整翻译强度可提高双特异性抗体的组装效率,并降低 CHO 细胞中的产品相关杂质。
Biotechnol Bioeng. 2020 Jul;117(7):1946-1960. doi: 10.1002/bit.27347. Epub 2020 Apr 21.
7
SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell level.SPLICELECTTM:一种基于可变剪接的适应性细胞表面展示技术,可在单细胞水平上定性和定量预测分泌产物。
MAbs. 2020 Jan-Dec;12(1):1709333. doi: 10.1080/19420862.2019.1709333.
8
Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies.天然和重组IgG抗体的宏观和微观异质性
Antibodies (Basel). 2019 Feb 19;8(1):18. doi: 10.3390/antib8010018.
9
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.免疫球蛋白结构域界面交换作为生成Fc异二聚体和双特异性抗体的平台技术。
J Biol Chem. 2017 Jun 9;292(23):9745-9759. doi: 10.1074/jbc.M117.782433. Epub 2017 Apr 27.
10
Optimizing assembly and production of native bispecific antibodies by codon de-optimization.通过密码子去优化来优化天然双特异性抗体的组装和生产。
MAbs. 2017 Feb/Mar;9(2):231-239. doi: 10.1080/19420862.2016.1267088.